AlGlutamine LLC licenses its underlying technology from the University of Virginia. The firm is focused to developing glutamine derivatives to be used in oral hydration and nutrition therapy. The Companyâs stable glutamine derivative products provide significant medical and economic benefits when combined with traditional nutritional supplements, sports beverages, rehydration therapy programs, chemotherapy programs and the like. The Company is currently evaluating appropriate licensing partners in these and other markets. AlGlutamine LLC is making its patented and patent-pending glutamine derivative products, manufacturing processes, and C. difficile toxin-blocking drugs available to a selected number of world class partners for use in a wide range of medical, non-medical, and veterinary applications
